Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2024-07-11 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2024-07-11 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of 19th Annual General Meeting' and contains a detailed summary of the AGM held on July 11, 2024. It includes information about the meeting's start and end times, directors present, shareholders attendance, agenda items discussed, resolutions passed, and voting procedures. The document is a summary of the AGM proceedings rather than the full Annual Report or financial statements. It does not contain detailed financial data or full reports but rather a record of the meeting events and decisions. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document length is 6935 characters, sufficient to provide a detailed summary but not a full report. Therefore, the correct classification is AGM Information (AGM-R).
2024-07-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges under Regulation 30 of SEBI (LODR) Regulations, 2015. It informs about the receipt of the Establishment Inspection Report (EIR) from the USFDA following an inspection at the company's manufacturing facilities. The document is brief (1749 characters), contains no financial data or detailed report content, and serves as an announcement of an event rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-06-29 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window pursuant to SEBI regulations ahead of the unaudited quarterly financial results announcement. It does not contain any financial data or results itself, nor does it provide detailed financial analysis or report. The document is primarily an announcement related to compliance and insider trading restrictions before the upcoming quarterly results. Given the short length (1216 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2024-06-28 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. It provides an update on the company's credit rating reaffirmation and outlook revision by CARE Ratings. The content is an announcement of a credit rating update, not a financial report or detailed analysis. The document length is short (1814 characters), and it serves as a regulatory announcement rather than a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-21 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a detailed notice and advertisement related to the Annual General Meeting (AGM) of a company, including information about the meeting date, voting procedures, electronic dispatch of the Notice and Annual Report, and other AGM logistics. It references the 19th AGM and the dispatch of the Annual Report for FY 2023-24 but does not contain the full Annual Report itself. The document is lengthy (15,000 characters) and includes procedural details and regulatory compliance information related to the AGM. It is not the Annual Report (10-K) itself, nor is it a simple announcement of report publication (RPA). The content aligns with materials shared or related to the AGM, such as notices, advertisements, and voting instructions, which fits the category of AGM Information (AGM-R).
2024-06-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.